Curiosity Stocks - Price range: $0 - $1
7.0: PAYOW : Payoneer Global Inc. Warrant : ~ Price 0.8499
N/A
_
Company Web Site
____________
Summary Pages
____________
0.383:0.0:1
7.0: PBAXW : Phoenix Biotech Acquisition Corp. Warrants : ~ Price 0.071
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
7.0: PCCTW : Perception Capital Corp. II Warrants : ~ Price 0.1099
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
6.0: ADILW : Adial Pharmaceuticals Inc Warrant : ~ Price 0.0057
_
Company Web Site
____________
Summary Pages
____________
0.410:7.0:2
6.0: AMBO : Ambow Education Holding Ltd. American Depository Shares each representing two Class A ordinary shares : ~ Price 0.191
Ambow Education Holding Ltd. is a leading national provider of educational and career enhancement services in China, offering high-quality, individualized services and products. With its extensive network of regional service hubs complemented by a dynamic proprietary learning platform and distributors, Ambow provides its services and products to students in 15 out of the 34 provinces and autonomous regions within China.
_
Company Web Site
____________
Summary Pages
____________
11.185:35.0:4
6.0: PPYAW : Papaya Growth Opportunity Corp. I Warrant : ~ Price 0.0732
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
5.0: AEACW : Authentic Equity Acquisition Corp. Warrant : ~ Price 0.0009
_
Company Web Site
____________
Summary Pages
____________
0.570:6.0:2
5.0: CPAAW : Conyers Park III Acquisition Corp. Warrants : ~ Price 0.001
_
Company Web Site
____________
Summary Pages
____________
0.890:4.0:2
5.0: AGGRW : Agile Growth Corp. Warrant. : ~ Price 0.003
_
Company Web Site
____________
Summary Pages
____________
0.605:11.0:2
5.0: BLEUW : bleuacacia ltd Warrants : ~ Price 0.0437
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
5.0: ALORW : ALSP Orchid Acquisition Corporation I Warrant : ~ Price 0.0362
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
5.0: ARIZW : Arisz Acquisition Corp. Warrant : ~ Price 0.0213
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
5.0: ARTEW : Artemis Strategic Investment Corporation Warrant : ~ Price 0.0351
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
5.0: ASCBW : A SPAC II Acquisition Corp. Warrant : ~ Price 0.0361
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
5.0: ATAKW : Aurora Technology Acquisition Corp. Warrants : ~ Price 0.0129
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
5.0: AUROW : Aurora Innovation Inc. Warrant : ~ Price 0.492
N/A
_
Company Web Site
____________
Summary Pages
____________
0.211:0.0:1
5.0: KACLW : Kairous Acquisition Corp. Limited Warrants : ~ Price 0.0063
N/A
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
4.0: RCHGW : Recharge Acquisition Corp. Warrant : ~ Price 0.0001
_
Company Web Site
____________
Summary Pages
____________
0.405:12.0:2
4.0: AKICW : Sports Ventures Acquisition Corp. Warrant : ~ Price 0.002
_
Company Web Site
____________
Summary Pages
____________
0.425:8.0:2
4.0: AGILW : AgileThought Inc. Warrant : ~ Price 0.0042
_
Company Web Site
____________
Summary Pages
____________
2.600:6.0:2
4.0: WALDW : Waldencast Acquisition Corp. Warrant : ~ Price 0.7837
_
Company Web Site
____________
Summary Pages
____________
0.883:1.0:2
4.0: AIMDW : Ainos Inc. Warrants : ~ Price 0.10
_
Company Web Site
____________
Summary Pages
____________
1.737:3.0:2
4.0: AMCIW : AMCI Acquisition Corp. II Warrant : ~ Price 0.3351
_
Company Web Site
____________
Summary Pages
____________
4.459:34.0:1
4.0: AMPGW : Amplitech Group Inc. Warrants : ~ Price 0.303
_
Company Web Site
____________
Summary Pages
____________
0.865:2.0:2
4.0: KUKE : Kuke Music Holding Limited American Depositary Shares each representing one Ordinary Share : ~ Price 0.72
Kuke Music Holding Limited ('Kuke') is the leading provider of classical music licensing, subscription, and education services in China. As of December 31, 2019, Kuke had the largest library of classical music content in Chinaand, in 2019, Kuke was the largest classical music licensing service provider and the second largest online classical music subscription service provider in China, according to Frost & Sullivan. Kuke leverages its rich and diverse content offerings and deep expertise in music education to offer innovative and efficient smart music education solutions, which primarily consist of its proprietary Kuke smart pianos, Kuke smart teaching systems and Kukey courses. Kuke is also the organizer of several live classical musical events in China, including the Beijing Music Festival, which is one of the most renowned musical events in the world. Through these three highly synergistic business lines, Kuke has formed a thriving content-centric ecosystem, positioning it well to continuously provide its customers with differentiated value propositions.
_
Company Web Site
____________
Summary Pages
____________
0.460:1.0:2
4.0: ADVWW : Advantage Solutions Inc. Warrant : ~ Price 0.2701
_
Company Web Site
____________
Summary Pages
____________
1.965:5.0:2
4.0: BCDAW : BioCardia Inc. Warrant : ~ Price 0.2572
_
Company Web Site
____________
Summary Pages
____________
0.737:3.0:2
3.0: TEKKW : Tekkorp Digital Acquisition Corp. Warrant : ~ Price 0.0002
_
Company Web Site
____________
Summary Pages
____________
1e-06.000:0.0:1
3.0: VPCBW : VPC Impact Acquisition Holdings II Warrant : ~ Price 0.001
_
Company Web Site
____________
Summary Pages
____________
0.690:23.0:2
3.0: SSAAW : Science Strategic Acquisition Corp. Alpha Warrant : ~ Price 0.0028
_
Company Web Site
____________
Summary Pages
____________
0.380:5.0:2
3.0: ACAHW : Atlantic Coastal Acquisition Corp. Warrant : ~ Price 0.0066
_
Company Web Site
____________
Summary Pages
____________
0.525:13.0:2
3.0: KITTW : Nauticus Robotics Inc. Warrant : ~ Price 0.1955
_
Company Web Site
____________
Summary Pages
____________
3.285:12.0:2
3.0: SVVC : Firsthand Technology Value Fund Inc. Common Stock : ~ Price 0.4601
Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies.
_
Company Web Site
____________
Summary Pages
____________
23.296:16.0:3
3.0: SWAGW : Software Acquisition Group Inc. III Warrant : ~ Price 0.0601
_
Company Web Site
____________
Summary Pages
____________
6.050:22.0:2
3.0: PXSAW : Pyxis Tankers Inc. Warrant : ~ Price 0.9895
_
Company Web Site
____________
Summary Pages
____________
0.430:1.0:1
3.0: RBT : Rubicon Technologies Inc. Class A Common Stock : ~ Price 0.4698
_
Company Web Site
____________
Summary Pages
____________
5.738:4.0:5
3.0: QRTEA : Qurate Retail Inc. Series A Common Stock : ~ Price 0.618
Qurate Retail, Inc. operates and owns interests in a broad range of digital commerce businesses. Qurate Retail, Inc.'s businesses and assets consist of QVC (and its subsidiaries, including HSN), Zulily and the Cornerstone Brands (collectively, the Qurate Retail Group) as well as various green energy and other investments.
_
Company Web Site
____________
Summary Pages
____________
4.175:2.0:6
3.0: AMPE : Ampio Pharmaceuticals Inc. : ~ Price 0.2155
Ampio Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company primarily engaged in the development of AmpionTM, its lead anti-inflammatory drug, which is currently undergoing clinical trials focused on the treatment of patients afflicted with COVID-19 induced acute respiratory distress syndrome (ARDS) as well as patients suffering from severe (KL-4) osteoarthritis of the knee (OAK). Both conditions impact a significant percentage of the population and due to the lack of any FDA approved drugs for treatment, there exists a significant unmet medical need. Ampion is backed by an extensive global patent portfolio with intellectual property protection extending through 2035. In addition, Ampion will be eligible for 12-year FDA market exclusivity upon approval as a novel biologic under the biologics price competition and innovation act (BPCIA).
_
Company Web Site
____________
Summary Pages
____________
1.824:24.0:5
3.0: AAU : Almaden Minerals Ltd. Common Shares : ~ Price 0.123
Almaden Minerals Ltd. owns 100% of the feasibility-stage Ixtaca project in Puebla State, Mexico, subject to a 2.0% NSR royalty held by Almadex Minerals Ltd. The Ixtaca Gold-Silver Deposit was discovered by Almaden in 2010.
_
Company Web Site
____________
Summary Pages
____________
0.310:1.0:4
3.0: AGIL : AgileThought Inc. Class A Common Stock : ~ Price 0.1436
LIV Capital Acquisition Corp. was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus on Mexican target businesses (or nonMexican target businesses with a significant presence in Mexico).
_
Company Web Site
____________
Summary Pages
____________
5.492:1.0:5
3.0: QTT : Qutoutiao Inc. American Depositary Shares : ~ Price 0.69
_
Company Web Site
____________
Summary Pages
____________
7.962:16.0:4
3.0: VSSYW : Versus Systems Inc. Class A Warrants : ~ Price 0.0116
_
Company Web Site
____________
Summary Pages
____________
0.525:8.0:2
3.0: ALNA : Allena Pharmaceuticals Inc. Common Stock : ~ Price 0.1037
Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class, oral biologic therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena's lead product candidate, reloxaliase, is currently being evaluated in a pivotal Phase 3 clinical program for the treatment of enteric hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders. Allena is also developing ALLN-346 for the treatment of hyperuricemia in the setting of gout and advanced chronic kidney disease, with a Phase 1 multiple-ascending dose study and a Phase 2a program planned for 2021.
_
Company Web Site
____________
Summary Pages
____________
1.665:16.0:4
3.0: ALSAR : Alpha Star Acquisition Corporation Rights : ~ Price 0.1001
_
Company Web Site
____________
Summary Pages
____________
5.930:35.0:2
3.0: VIRI : Virios Therapeutics Inc. Common Stock : ~ Price 0.999
Virios Therapeutics is a development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ('FM'). Overactive immune response related to activation of tissue resident Herpes Simplex Virus-1 ('HSV-1') has been postulated to be a potential root cause of chronic illnesses such as FM, irritable bowel disease ('IBS'), chronic fatigue syndrome and functional somatic syndrome, all of which are characterized by a waxing and waning manifestation of disease. While not completely understood, there is general agreement in the medical community that activation of HSV-1 is triggered by some form of environmental and/or health stressor. Our lead development candidate ('IMC-1'), is a novel, proprietary, fixed dose combination of famciclovir and celecoxib. IMC-1 represents a novel combination antiviral therapy designed to synergistically suppress HSV-1 activation and replication, with the end goal of reducing viral mediated disease burden.
_
Company Web Site
____________
Summary Pages
____________
1.260:4.0:2
3.0: AGTC : Applied Genetic Technologies Corporation Common Stock : ~ Price 0.376
Applied Genetic Technologies Corp. (AGTC) is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC's most advanced clinical programs leverage its best-in-class technology platform to potentially improve vision for patients with an inherited retinal disease. AGTC has active clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 and ACHM CNGA3). Its preclinical programs build on the Company's industry leading AAV manufacturing technology and scientific expertise. AGTC is advancing multiple important pipeline candidates to address substantial unmet clinical need in optogenetics, otology and CNS disorders. In recent years AGTC has entered into strategic partnerships with companies including Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, and Bionic Sight, an innovator in the emerging field of optogenetics and retinal coding.
_
Company Web Site
____________
Summary Pages
____________
7.675:26.0:6
3.0: POL : Polished Inc. Common Stock : ~ Price 0.1088
1847 Goedeker Inc. operates as an online consumer goods retailer. The Company offers microwave ovens, grills, fridge, dishwashers, dryers, space heaters, furniture, rugs, garbage disposals, lamps, and home improvement products. 1847 Goedeker markets its products in the United States.
_
Company Web Site
____________
Summary Pages
____________
2.684:5.0:5
3.0: CETXW : Cemtrex Inc. Series 1 Warrant : ~ Price 0.0151
_
Company Web Site
____________
Summary Pages
____________
0.120:8.0:1
3.0: ACONW : Aclarion Inc. Warrant : ~ Price 0.1401
_
Company Web Site
____________
Summary Pages
____________
0.735:5.0:2
3.0: ACRX : AcelRx Pharmaceuticals Inc. Common Stock : ~ Price 0.8684
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. AcelRx has one approved product in the U.S., DSUVIA® (sufentanil sublingual tablet, 30 mcg), known as DZUVEO™ in Europe, indicated for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings, and one product candidate, Zalviso® (sufentanil sublingual tablet system, SST system, 15 mcg), an investigational product in the U.S., is being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings. DZUVEO and Zalviso are both approved products in Europe.
_
Company Web Site
____________
Summary Pages
____________
2.888:12.0:6
3.0: ROCRW : Roth CH Acquisition III Co. Warrant : ~ Price 0.6398
_
Company Web Site
____________
Summary Pages
____________
0.744:1.0:2
3.0: PRLHW : Pearl Holdings Acquisition Corp Warrant : ~ Price 0.0566
N/A
_
Company Web Site
____________
Summary Pages
____________
0.744:1.0:2
3.0: PROCW : Procaps Group S.A. Warrants : ~ Price 0.1149
N/A
_
Company Web Site
____________
Summary Pages
____________
0.744:1.0:2
3.0: AFMD : Affimed N.V. : ~ Price 0.5154
Affimed is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company's proprietary ROCK® platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK platform predictably generates customized innate cell engager (ICE®) molecules, which use patients' immune cells to destroy tumor cells. This innovative approach enabled Affimed to become the first company with a clinical-stage ICE®. Headquartered in Heidelberg, Germany, with offices in New York, New York, Affimed is led by an experienced team of biotechnology and pharmaceutical leaders united by a bold vision to stop cancer from ever derailing patients' lives.
_
Company Web Site
____________
Summary Pages
____________
6.985:3.0:6
3.0: AFRIW : Forafric Global PLC Warrants : ~ Price 0.96
_
Company Web Site
____________
Summary Pages
____________
7.457:19.0:2
3.0: AIH : Aesthetic Medical International Holdings Group Ltd. American Depositary Shares : ~ Price 0.78
Aesthetic Medical International Holdings Group Limited, founded in Shenzhen, China in 1997, is an international listed group specialized in aesthetic medical services as well as the first aesthetic medical services organization listed in China's main board. AIH has always prioritized the safety and quality of aesthetic services, making it one of aesthetic services institutions with the best medical safety records as well as with the longest history in the industry and thus enjoying prestige in the society and among consumers.
_
Company Web Site
____________
Summary Pages
____________
7.680:3.0:4
3.0: ADERW : 26 Capital Acquisition Corp. Warrant : ~ Price 0.012
_
Company Web Site
____________
Summary Pages
____________
0.750:3.0:1
3.0: ADOCR : Edoc Acquisition Corp. Right : ~ Price 0.19
_
Company Web Site
____________
Summary Pages
____________
0.220:1.0:2
3.0: ADOCW : Edoc Acquisition Corp. Warrant : ~ Price 0.0166
_
Company Web Site
____________
Summary Pages
____________
0.125:3.0:2
3.0: AGBAR : AGBA Acquisition Limited Right : ~ Price 0.3999
_
Company Web Site
____________
Summary Pages
____________
0.210:2.0:2
3.0: AGBAW : AGBA Acquisition Limited Warrant : ~ Price 0.0353
_
Company Web Site
____________
Summary Pages
____________
0.145:3.0:2
3.0: ALACR : Alberton Acquisition Corporation Rights exp April 26 2021 : ~ Price 0.0703
_
Company Web Site
____________
Summary Pages
____________
0.337:5.0:2
3.0: ALACW : Alberton Acquisition Corporation Warrant : ~ Price 0.0225
_
Company Web Site
____________
Summary Pages
____________
0.340:15.0:1
Curiosity Stocks - Price range: $1 - $5
List of Curiosity Stocks - Price range: $1 - $5
Curiosity Stocks - Price range: $5 - $10
List of Curiosity Stocks - Price range: $5 - $10
Curiosity Stocks - Price range: $10 - $50
List of Curiosity Stocks - Price range: $10 - $50
Curiosity Stock Price range: $50 - $100
List of Curiosity Stocks - Price range: $50 - $100
|
|
|
